In its initial announcements, CMS indicated that the GLP-1 Bridge program would run from July 1, 2026, through the end of the year, with the BALANCE Model beginning in January 2027
The researchers note that future studies should directly compare surgery with newer GLP-1 therapies, such as semaglutide and tirzepatide, to further guide treatment decisions
At this point, Semaglutide is usually at its full therapeutic dose, and results can become even more noticeable if paired with nutrition guidance and physical activity
Dank der professionellen Lyophilisierung ist das Retatrutide-Pulver im ungelsten Zustand uerst temperaturstabil
Tirzepatide can cause higher rates of injection site reactions
Save high-fiber foods for post-workout or evening meals